Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders

Apostolia M. Tsimberidou, Dawn E. Colburn, Mary Alma Welch, Jorge E. Cortes, Srdan Verstovsek, Susan M. O'Brien, Maher Albitar, Hagop M. Kantarjian, Francis J. Giles*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds